| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP0889042B1 Radicicol derivatives |
| 05/06/2004 | CA2502282A1 Process for making spirolactone compounds |
| 05/05/2004 | CN1494171A 膜形成方法 Film forming method |
| 05/04/2004 | US6730803 Production method of a beta -keto ester compound of claim 1, which comprises condensation of a 2-cyano-2,2-dimethylacetate solution to give 2-cyano-2,2- dimethylacetate of the formula (ii), and condensation thereof |
| 04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
| 04/29/2004 | WO2004034990A2 Methods and compositions for use in treating cancer |
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 04/29/2004 | US20040082809 Reacting an anhydride with an alcohol; partial esterification |
| 04/29/2004 | US20040082651 Epothilone synthesis building blocks III and IV: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones B, D and epothilone derivatives |
| 04/29/2004 | US20040082519 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 04/29/2004 | US20040082066 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 04/29/2004 | DE19929573B4 Verfahren zur Herstellung von Pyromellitsäuredianhydrid A process for producing pyromellitic dianhydride |
| 04/28/2004 | EP1412322A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof |
| 04/28/2004 | EP0777662B1 Ring d-modified gibberellin compounds, and preparation and use thereof |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1491950A Extracting process for bilobalide A, B, C and its preparation |
| 04/28/2004 | CN1147298C Prevention and curing agent for hepatitis C |
| 04/27/2004 | US6728383 Method of compensating for hearing loss |
| 04/27/2004 | US6727276 Epothilone derivatives for the treatment of refractory tumors |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727098 Circular dichroism |
| 04/22/2004 | WO2004033462A2 METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO [2, 3-b] FURAN AND RELATED COMPOUNDS |
| 04/22/2004 | WO2003070159A3 Novel coumarin and chromene compounds and methods of treating or preventing viral infections |
| 04/22/2004 | WO2003007878A3 Antifungal agents of sordarin derivatives |
| 04/22/2004 | US20040077883 Suspending plant material or extract in the presence of an oxidizer, extracting terpene trilactones and separating |
| 04/22/2004 | DE10197218T5 Neue Dioxin-Analoga, Verfahren und Kits zum Screening nach Organismen oder Enzymen, die zum Abbau von Dioxinen in der Lage sind, oder Genen, die ein zum Abbau von Dioxinen befähigtes Enzym codieren New dioxin analogs, methods and kits for screening for organisms or enzymes for the degradation of dioxins in a position or genes that encode an enzyme for degradation of dioxins UNTRAINED |
| 04/21/2004 | EP1408957A2 Triptolide prodrugs having high aqueous solubility |
| 04/21/2004 | EP1033130B1 Inhibitor of urokinase production and of angiogenesis and its therapeutic use |
| 04/20/2004 | US6723859 Chromene compound |
| 04/20/2004 | US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/20/2004 | US6723395 Chiral compounds |
| 04/20/2004 | CA2300382C New psoralens for pathogen inactivation |
| 04/20/2004 | CA2256479C Novel photochromic heterocyclic fused indenonaphthopyrans |
| 04/15/2004 | WO2004031168A2 Processes and intermediates for the preparation of optically active 3-amino-1-(2-thienyl)-1-propanol derivatives |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003045324A3 14-methyl-epothilones |
| 04/15/2004 | WO2003022844A9 Synthesis of epothilones intermediates thereto and analogues thereof |
| 04/15/2004 | US20040072899 Antiinflammatory agents; antipyretics; analgesics |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072870 Anticancer agents |
| 04/15/2004 | US20040072252 Heteroaryl substituted benzothiazole dioxetanes |
| 04/14/2004 | EP1309598A4 Fluorescent compounds |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1488632A Purifying method for obtaining high-purity pyromellitic dianhydride |
| 04/13/2004 | US6720430 Heterocyclic lacton acrylate ester monomers; isobenzofuran acrylate esters; 4,7-methanoisobenzofuran acrylate esters; 4,7-epoxyisobenzofuran acrylate esters |
| 04/13/2004 | US6720353 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units |
| 04/13/2004 | US6719925 Photochromism; ophthalmic lenses |
| 04/13/2004 | US6719540 C3-cyano epothilone derivatives |
| 04/13/2004 | CA2276747C Methods and devices for the reduction of small organic compounds from blood products |
| 04/08/2004 | WO2004028476A2 Artemisinin-derived trioxane dimers |
| 04/08/2004 | WO2004028445A2 Processes for preparing 1,3-dioxolane nucleosides |
| 04/08/2004 | US20040068124 Capable of forming a polymer which is effectively acid-decomposable and can control the diffusion of the acid generated upon exposure |
| 04/08/2004 | US20040068004 For plants; fungicides, bactericides |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404680A2 Process for preparing intermediates of hiv protease inhibitors |
| 04/07/2004 | EP1404342A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics |
| 04/07/2004 | EP0918776B1 Total synthesis of antitumor acylfulvenes |
| 04/07/2004 | EP0741731B1 Process for epoxidising prochiral olefins |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1486771A Method for recorering sublimates |
| 04/07/2004 | CN1486712A Extractive of Chinese medicinal material rabdosia as antitumor medicine and its prepn process |
| 04/07/2004 | CN1144798C Process for producing oxetane |
| 04/06/2004 | US6717017 4'-alkyl,6'-(protected hydroxy),7'-hydroxy-spiro(cyclopropane-1,5'-hexahydroindan-2,3 a(4),7a(1)-triene) compound of given formula, intermediate to illudin analogs of the mushroom omphalotus illudens |
| 04/06/2004 | US6716864 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | US6716439 Gels comprising novel fluorinated and alkylated alditol derivatives |
| 04/06/2004 | CA2121060C Preparation of lignan analogues |
| 04/01/2004 | WO2004026298A1 Derivatives of triptolide having high immunosuppressive effect and high water solubility, and uses thereof |
| 04/01/2004 | WO2004026254A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | WO2004009074A3 A multi-ring regulator of gut motility and food intake |
| 04/01/2004 | WO2003103602A3 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/01/2004 | WO2003099780A3 Luminogenic protease substrates |
| 04/01/2004 | WO2003082875A3 Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics |
| 04/01/2004 | US20040063975 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation |
| 04/01/2004 | US20040063968 Process for use in 11-oxa prostaglandin synthesis |
| 04/01/2004 | US20040063882 (Meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
| 04/01/2004 | US20040063778 Compounds having improved stability over that of natural benzolactones, and a process for synthesizing them; anticancer activity and inhibit V-ATPase activity |
| 04/01/2004 | US20040063663 Acylated cyclodextrin: guest molecule inclusion complexes |
| 04/01/2004 | US20040062754 Photopheresis treatment of chronic HCV infections |
| 04/01/2004 | CA2695720A1 Method of producing epothilone b by culturing sorangium cellulosum in a medium comprising propionic acid |
| 04/01/2004 | CA2695671A1 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 03/31/2004 | EP1403295A2 Ester compounds, polymers, resist compositions and patterning process |
| 03/31/2004 | EP1401830A2 Quinazolinediones as antibacterial agents |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/30/2004 | CA2057760C Salinomycin biomass granules which are free-flowing and dust-free and have unrestricted bioavailability of active substance, and a process for the production thereof |
| 03/25/2004 | WO2004024735A2 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | US20040059100 Metallating 2-hydroxyacetophenone compound using a lithium compound and subsequently reacted with a keto compound such as 3,4-dimethoxybenzoyl chloride; specific stoichiometry of Li compound |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |